44 Recruiting Prostatic Neoplasms Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Prostatic Neoplasms
Related Conditions
Top Recruiting Prostatic Neoplasms Studies
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔PSMA PET/CT for Assessment of Recurrent Prostate Cancer
📍 BC Cancer — Vancouver, British Columbia
View Study & Checklist ➔An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
📍 Clinical Research Facility — Homewood, Alabama
View Study & Checklist ➔A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
📍 Clinical Research Facility — Los Angeles, California
View Study & Checklist ➔Contributions of a Paramedical Approach in the Prevention and Treatment of Side Effects Associated With Radical Prostatectomy
📍 Centre Hospitalier Universitaire de Martinique — Fort-de-France,
View Study & Checklist ➔A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
📍 Clinical Research Facility — Birmingham, Alabama
View Study & Checklist ➔An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
📍 Clinical Research Facility — Phoenix, Arizona
View Study & Checklist ➔A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
📍 Arizona Oncology Associates, P.C. - HOPE — Prescott, Arizona
View Study & Checklist ➔Evaluation of Atherosclerotic Plaques in Abdominal CT Studies
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
📍 Hotel-Dieu of Quebec — Québec, Quebec
View Study & Checklist ➔A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
📍 Columbia University Medical Center Herbert Irving Pavilion — New York, New York
View Study & Checklist ➔A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer
📍 Arizona Urology Specialists — Tucson, Arizona
View Study & Checklist ➔18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer
📍 Columbia University Irving Medical Center — New York, New York
View Study & Checklist ➔A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
📍 START Mountain Region — West Valley City, Utah
View Study & Checklist ➔An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
📍 Mayo Clinic - Arizona Mayo Clinic Hospital — Scottsdale, Arizona
View Study & Checklist ➔Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer
📍 Rocky Mountain Cancer Centers — Denver, Colorado
View Study & Checklist ➔A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
📍 Florida Cancer Specialists — Sarasota, Florida
View Study & Checklist ➔Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
📍 Houston Methodist — Houston, Texas
View Study & Checklist ➔18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
📍 VA Greater Los Angeles Healthcare System — Los Angeles, California
View Study & Checklist ➔Prostate Active Surveillance Study
📍 Veterans Affairs San Francisco Health Care System — San Francisco, California
View Study & Checklist ➔A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics
📍 Precision Point Specialty LLC PPS Analytics, a Specialty Networks LLC Company — Cleveland, Ohio
View Study & Checklist ➔Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
📍 Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔Men at High Genetic Risk for Prostate Cancer
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
📍 Florida Cancer Specialists — Sarasota, Florida
View Study & Checklist ➔A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
📍 University of Colorado Anschutz Medical Campus — Aurora, Colorado
View Study & Checklist ➔Dose Escalation For INtraprostatic LEsions
📍 The Ottawa Hospital Cancer Centre — Ottawa, Ontario
View Study & Checklist ➔Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔